gilead sciences reports quarterly earnings miss
Published 5 years ago • 475 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
0:49
gilead's remdesivir brought in $873 million during the third quarter
-
0:58
gilead beats, announces ceo stepping down
-
0:54
gilead sciences beats earnings, revenues expectations
-
1:46
gilead earnings, revenue both miss
-
2:14
gilead slashing prices of top-selling hepatitis c drugs
-
1:41
gilead earnings, revenue in line
-
4:59
gilead downgraded to underperform at credit suisse
-
3:47
kontoor brands ceo scott baxter on q3 earnings beat
-
6:45
gilead sciences (gild) stock analysis 2024 | gild stock buy or? #dividendstocks2024 #gild #gilead
-
12:39
my thoughts on gilead stock (and biotech in general)
-
9:54
pfizer ceo discusses q3 earnings, 'exceptional' growth
-
1:59
#askhalftime: gilead, merck & greenbrier
-
4:48
gilead sciences ceo daniel o'day on the collaboration with biotech firm galapagos
-
3:15
options traders see more upside in gilead
-
7:25
goldman cuts gilead to sell
-
5:33
technician reacts to gilead earnings and the biotech space
-
1:17
gilead beats eps expectations by $0.10; amgen raises low end of full-year revenue outlook
-
1:17
gilead sciences stock surges amid earnings beat and analyst upgrades
-
1:25
gilead shares sink as the fda rejects the company's arthritis drug
-
7:07
traders on facebook, starbucks & gilead shares after earnings
-
2:31
final trades: gilead, paypal, rh, delta and flir
-
5:31
watch cnbc's full interview with gilead ceo dan o'day